Header Image
News Room / Auxellence Announces Notice of Annual General and Special Meeting

Auxellence Announces Notice of Annual General and Special Meeting

VANCOUVER, BC / ACCESSWIRE / Thursday, May 15, 2014 - Auxellence Health Corporation (CSE:AID) (the "Company" or "Auxellence") today announces that it has delivered all materials required to its transfer agent Computershare Trust Company of Canada / Computershare Investor Services Inc. yesterday before noon Wednesday May 14th, 2014 to mail-out to shareholders at the upcoming Annual General and Special Meeting scheduled on June 11th, 2014 for all shareholders of record as of May 2, 2014. The information circular was approved by the Board of Directors for mail out on Tuesday May 13th, 2014 as indicated in the body of the information circular and was sent out to the transfer agent before noon Wednesday May 14th, 2014 as required under NI 54-101. There information circular was erroneously dated May 15,2014 but should actually have been dated May 14th, 2014.

In addition the press release dated May 13th, 2014 regarding the Company signing additional Letters of Intent should have read Tuesday May 13th, 2014 instead of Thursday May 13th, 2014.

Management looks forward to seeing shareholders at the upcoming Annual General and Special Meeting to vote on the annual business of the Company and the Plan Of Arrangement.


Sydney Au, President & CEO

Auxellence Health Corporation

Email: [email protected]

Phone: (604) 780-3311

About Auxellence Health Corporation

Auxellence is a health technology company that aims to provide high-level online personal health services to consumers, providers and suppliers of OTC (Over-The-Counter) health care products and services, including refining the effectiveness of prescribing services to the OTC (Over-The-Counter) consumer pharmaceutical and natural health industry. The Company is integrating innovative therapeutic and diagnostic (theragnostic) devices (hardware components), along with an interactive Expert System and Recommender "PRESCRIPTOR" engine (software platform) to acquire physiological data for personalized medicine and health solutions to everyday health issues (initially targeting weight management and skin health conditions (acne)).

Disclaimer for Forward-Looking Information Statements in this press release regarding the Company which are not historical facts are "forward-looking statements" that involve risks and uncertainties. Such information can generally be identified by the use of forwarding-looking wording such as "may", "will", "expect", "estimate", "anticipate", "intend", "believe" and "continue" or the negative thereof or similar variations. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated in such statements due to factors. Except as required by law, the Company does not intend to update any changes to such statements. Although Management believes that the expectations represented in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.